Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Thermo Fisher Scientific Inc (NYSE:TMO)

158.98
Delayed Data
As of Feb 24
 +0.25 / +0.16%
Today’s Change
127.65
Today|||52-Week Range
160.68
+12.67%
Year-to-Date
Thermo Fisher Comes Out on Top in Promega Patent Case
Feb 22 / TheStreet.com - Paid Partner Content
 

Today’s Trading

Previous close158.73
Today’s open158.34
Day’s range157.58 - 158.98
Volume832,828
Average volume (3 months)1,974,239
Market cap$62.8B
Dividend yield0.38%
Data as of 4:00pm ET, 02/24/2017

Growth & Valuation

Earnings growth (last year)+3.46%
Earnings growth (this year)+10.72%
Earnings growth (next 5 years)+11.35%
Revenue growth (last year)+7.71%
P/E ratio31.7
Price/Sales3.07
Price/Book--

Competitors

 Today’s
change
Today’s
% change
DHRDanaher Corp+0.95+1.12%
AAgilent Technologies...+0.27+0.52%
WATWaters Corp+1.51+0.97%
MTDMettler-Toledo Inter...+2.84+0.60%
Data as of 4:04pm ET, 02/24/2017

Financials

Next reporting dateApril 26, 2017
EPS forecast (this quarter)$2.02
Annual revenue (last year)$18.3B
Annual profit (last year)$2.0B
Net profit margin11.08%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
Marc N. Casper
Chief Financial Officer &
Senior Vice President
Stephen Williamson
Corporate headquarters
Waltham, Massachusetts

Forecasts


Search for Jobs